Induction of P-glycoprotein expression on the plasma membrane of human melanoma cells

Citation
A. Molinari et al., Induction of P-glycoprotein expression on the plasma membrane of human melanoma cells, ANTICANC R, 20(4), 2000, pp. 2691-2696
Citations number
18
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
20
Issue
4
Year of publication
2000
Pages
2691 - 2696
Database
ISI
SICI code
0250-7005(200007/08)20:4<2691:IOPEOT>2.0.ZU;2-7
Abstract
Melanoma cells exhibit, both in vivo and in vitro, intrinsic drug resistanc e to various chemotherapeutic agents. Cultured human melanoma cells (M14) i ntrinsically express significant amounts of multidrug resistance-related pr otein (MRP1) and P-glycoprotein (P-gp) in the Golgi apparatus but do not ex press these drug transporters on the plasma membrane. A panel of multidrug resistant (MDR) melanoma cell lines (M14Dx) showing different degrees of re sistance to doxorubicin (DOX) were isolated. In M14Dx lines, the appearance of surface P-gp, but not of MRP1 or lung resistance related protein (LRP), occurred in cells grown in the presence of DOX concentrations higher than 60 nM. Furthermore, P-gp levels appeared to be dose-dependent. Flow cytomet ry, laser scanning confocal microscopy and cytotoxicity studies demonstrate d that the activity of the drug extrusion system was related to both surfac e P-gp expression and resistance to DOX. In conclusion, P-gp, but not MRP1 or LRP, might play a pivotal role in the pharmacologically-induced MDR phen otype of melanoma cells.